
Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Matoso is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an AP/CP board certified pathologist with sub specialty expertise in GI and GU pathology.
Education & Training
- Department of Pathology and Laboratory Medicine Johns Hopkins HospitalFellowship, Urologic Pathology, 2013
- Rhode Island Medical CenterFellowship, Gastrointestinal Pathology, 2012 - 2013
- Rhode Island Hospital/Brown University2008 - 2012
- Weill Cornell MedicinePost-Doctoral Fellowship, 2006 - 2008
- University of Buenos Aires2002 - 2005
- University of Buenos AiresClass of 2001
Certifications & Licensure
- DC State Medical License 2016 - 2027
- MD State Medical License 2012 - 2027
- FL State Medical License 2024 - 2026
- RI State Medical License 2013 - 2026
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of PathologyAP/CP
Awards, Honors, & Recognition
- Stowell-Orbison Award United States & Canadian Academy of Pathology, 2013
- New Investigator Award Winner Rhode Island Hospital/Brown University, 2012
- New Investigator Award Finalist Rhode Island Hospital/Brown University, 2010
- Join now to see all
Publications & Presentations
PubMed
- Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classific...Selena Odeh, Iryna Samarska, Andres Matoso, Marcella Mll Baldewijns, Christina A Hulsbergen-van de Kaa
The Journal of Pathology. Clinical Research. 2025-09-01 - National trends in diagnoses of subtype histologies in bladder cancer: A population-based study based on the SEER database.Brendan K Wallace, Zhuo Tony Su, James P Flynn, Tyler S Garman, Aidan Weitzner
Urologic Oncology. 2025-07-04 - Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of ...Andres M Acosta, Maurizio Colecchia, Eva Comperat, Kristine M Cornejo, Anthony J Gill
Histopathology. 2025-06-18
Journal Articles
- Association of Impaired Spermatogenesis with the Use of Immune Checkpoint Inhibitors in Patients with Metastatic MelanomaJody E Hooper, Andres Matoso, JAMA Oncology
- Expression Microarray Analysis Identifies of Novel Protein Markers in Eosinophilic Esophagitis.Matoso A, Mukkada VA, Lu S, Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB, Mod Pathol
- Sympathetic ophtalmia following enucleation.Tseng VL, Matoso A, Hofmann RJ, Graefes Arch Clin Exp Ophthalmol
Books/Book Chapters
Abstracts/Posters
- Molecular Mechanismsof Met Regulation by p53 in Ovarian Cancer.Matoso A, Hwang C-I, Flesken-Nikitin A, Ellenson LH, Nikitin AY, Center for Vertebrate Genomics, Annual Symposium
- Mutually Exclusive Mutations between Men1 and Rb in Neuroendocrine Neoplasia.Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY, Cornell University
- ALDH1 Expression in Bladder Cancer Correlates with Histopathologic Indicators of Poor Prognosis.Elsamra SE, Matoso A, Singh K, Tavares R, Noble L, Renzulli J, Haleblian G, Resnick MB, Wang LJ, Pareek G, New England Section of the American Urological Association
- Join now to see all
Lectures
- Differentially expressed proteins in eosinophilic esophagitis: identification of easily detectable markers with potential diagnostic utility.20th Annual Hospital Research Celebration
- Expression of stem cell marker ALDH1 correlates with muscle invasion in transitional cell carcinoma of the bladder.18th Annual Hospital Research Celebration
- Prostatic Lesions of Ductal Morphology.Pathology Grand Rounds, Rhode Island Hospital
- Join now to see all
Authored Content
- Association of Impaired Spermatogenesis with the Use of Immune Checkpoint Inhibitors in Patients with Metastatic MelanomaJune 2020
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: